monitoring banner image Sun
Welcome

LiDCO supplies minimally-invasive and non-invasive hemodynamic equipment to hospitals worldwide.
If you are looking to understand more about improving patient outcomes by reducing morbidity, complications, length of stay and overall costs associated with major surgery - we are here to help.

We can assist with implementing ERAS protocols, product evaluations, training, education and adoption.

Please contact us on +44 (0)20 7749 1500 or email us at info@lidco.com for more information.

  Latest News

loading...

  Annual Report now available!

View our reports here ...

Safe

  • Calibrated cardiac output values from existing radial and venous catheters
  • Dual finger cuff for non-invasive use
  • Extensively validated including when used with vasoactive drugs1,2,3

Proven

  • Only arterial waveform analysis algorithm unchanged in 15 years
  • Over 200 clinical studies4
  • Improved patient outcomes5,6,7,8

Flexible

  • Switch from non-invasive to invasive with the same disposable
  • LiDCOrapid can be calibrated with any valid cardiac output measurement
  • Hemodynamic management across the whole clinical pathway6

Unique

  • Single disposable for both invasive and dual cuff non-invasive monitoring
  • Non-invasive CNAP calibrated to brachial arm cuff
  • Depth of anaesthesia monitoring9
  • 96 hours of monitoring with single disposable
References
  • 1. Hadian M, Severyn D, Pinksy M. The effects of vasoactive drugs on pulse pressure + stroke volume variation in post-operative ventialated patients (2011_ Journal of Critical Care. Jun; 26 (3): 328. E1-8. Doi 10.1016/j.jrc.2010.08.015
  • 2. Mora B, Ince I, Birkenberg B, Skhirtladze K, Pernicka E, Ankersmit H.J Dworschak, M (2011) Validation of cardiac output measurement with the LIDCO™ pulse contour system in patients with impaired left ventricular fuction after cardiac surgery*. Anaesthesia 66(8):675-81
  • 3. Dyer R, Piercy J, Reed A, Strathie G, Lombard C, Anthony J, James M (2011) Comparison between pulse waveform analysis and thermodilution cardiac output determination in patients with severe pre-eclampsia. Brit Journal of Anaesthesia 106 (1) 77 – 81
  • 4. http://www.lidco.com/outcomes/outcomes.php
  • 5. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED (2005) Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial. Crit Care 9 (6) 687-693
  • 6. S. Huddart, C. J. Peden, M. Swart, B. McCormick, M. Dickinson, M. A. Mohammed and N. Quiney (2014) Use of a Care Bundle to Reduce Mortality after Emergency Lapartomy. British Journal of Surgery 2014; 10.1002/bjs.9658
  • 7. Thomson R, Meeran H, Valencia O, Al-Subaie N, Goal-Directed therapy following cardiac surgery and the incidence of acute kidney injury, Journal of Critical Care (2014), doi: 10.1016/j.jcrc.2014.06.011
  • 8. Hata J, Stotts C, Shelsky C, Bayman E, Frazier A, Wang J, Nickel E (2011) Reduced mortality with noninvasive hemodynamic monitoring of shock. J Crit Care vol 26 (2):224. E1-8
  • 9. Gan T, Glass P, Windsor A, Payne F, Rosow C, Sebel P, Manberg P. Bispectral index monitoring allows fsater emergence and improved recovery from propofol, alfentanil, and nistrous oxide anesthesia.BIS™ Utlity Sutdy Group. (1997) Anesthesiology, 87(4):808-815